Literature DB >> 19556876

Transcription factors LSF and E2Fs: tandem cyclists driving G0 to S?

Ulla Hansen1, Laura Owens, Utsav H Saxena.   

Abstract

Cell cycle progression in mammalian cells from G(1) into S phase requires sensing and integration of multiple inputs, in order to determine whether to continue to cellular DNA replication and subsequently, to cell division. Passage to S requires transition through the restriction point, which at a molecular level consists of a bistable switch involving E2Fs and pRb family members. At the G(1)/S boundary, a number of genes essential for DNA replication and cell cycle progression are upregulated, promoting entry into S phase. Although the activating E2Fs are the most extensively characterized transcription factors driving G(1)/S expression, LSF is also a transcription factor essential for stimulating G(1)/S gene expression. A critical LSF target gene at this stage, Tyms, encodes thymidylate synthetase. In investigating how LSF is activated in a cell cycle-dependent manner, we recently identified a novel time delay mechanism for regulating its activity during G(1) progression, which is apparently independent of the E2F/pRb axis. This involves inhibition of LSF in early G(1) by two major proliferative signaling pathways: ERK and cyclin C/CDK, followed by gradual dephosphorylation during mid- to late-G(1). Whether LSF and E2F act independently or in concert to promote G(1)/S progression remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556876      PMCID: PMC2796248          DOI: 10.4161/cc.8.14.9089

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  44 in total

Review 1.  Signaling networks that link cell proliferation and cell fate.

Authors:  Rosalie C Sears; Joseph R Nevins
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

Review 2.  Sibling rivalry in the E2F family.

Authors:  Jeffrey M Trimarchi; Jacqueline A Lees
Journal:  Nat Rev Mol Cell Biol       Date:  2002-01       Impact factor: 94.444

Review 3.  The genetics of the E2F family of transcription factors: shared functions and unique roles.

Authors:  James DeGregori
Journal:  Biochim Biophys Acta       Date:  2002-06-21

4.  Late Simian virus 40 transcription factor is a target of the phosphoinositide 3-kinase/Akt pathway in anti-apoptotic Alzheimer's amyloid precursor protein signalling.

Authors:  Tarek Kashour; Teralee Burton; Alexander Dibrov; Francis M Amara
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

5.  Targeted disruption of the CP2 gene, a member of the NTF family of transcription factors.

Authors:  L Ramamurthy; V Barbour; A Tuckfield; D R Clouston; D Topham; J M Cunningham; S M Jane
Journal:  J Biol Chem       Date:  2000-09-19       Impact factor: 5.157

6.  Inhibition of the mammalian transcription factor LSF induces S-phase-dependent apoptosis by downregulating thymidylate synthase expression.

Authors:  C M Powell; T L Rudge; Q Zhu; L F Johnson; U Hansen
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

7.  Fe65, a ligand of the Alzheimer's beta-amyloid precursor protein, blocks cell cycle progression by down-regulating thymidylate synthase expression.

Authors:  Paola Bruni; Giuseppina Minopoli; Tiziana Brancaccio; Maria Napolitano; Raffaella Faraonio; Nicola Zambrano; Ulla Hansen; Tommaso Russo
Journal:  J Biol Chem       Date:  2002-06-27       Impact factor: 5.157

8.  CRTR-1, a developmentally regulated transcriptional repressor related to the CP2 family of transcription factors.

Authors:  S Rodda; S Sharma; M Scherer; G Chapman; P Rathjen
Journal:  J Biol Chem       Date:  2000-11-09       Impact factor: 5.486

9.  Cdk1 is sufficient to drive the mammalian cell cycle.

Authors:  David Santamaría; Cédric Barrière; Antonio Cerqueira; Sarah Hunt; Claudine Tardy; Kathryn Newton; Javier F Cáceres; Pierre Dubus; Marcos Malumbres; Mariano Barbacid
Journal:  Nature       Date:  2007-08-16       Impact factor: 49.962

10.  A highly conserved novel family of mammalian developmental transcription factors related to Drosophila grainyhead.

Authors:  Tomasz Wilanowski; Annabel Tuckfield; Loretta Cerruti; Sinead O'Connell; Robert Saint; Vishwas Parekh; Jianning Tao; John M Cunningham; Stephen M Jane
Journal:  Mech Dev       Date:  2002-06       Impact factor: 1.810

View more
  18 in total

Review 1.  AEG-1/MTDH/LYRIC in liver cancer.

Authors:  Devanand Sarkar
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 2.  Network calisthenics: control of E2F dynamics in cell cycle entry.

Authors:  Jeffrey V Wong; Peng Dong; Joseph R Nevins; Bernard Mathey-Prevot; Lingchong You
Journal:  Cell Cycle       Date:  2011-09-15       Impact factor: 4.534

3.  Prolyl isomerase Pin1 regulates transcription factor LSF (TFCP2) by facilitating dephosphorylation at two serine-proline motifs.

Authors:  Utsav H Saxena; Laura Owens; Julie R Graham; Geoffrey M Cooper; Ulla Hansen
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

4.  Vasoactive intestinal peptide induces proliferation of human hepatocytes.

Authors:  M E M S Khedr; A M Abdelmotelb; T A Bedwell; A Shtaya; M N Alzoubi; M Abu Hilal; S I Khakoo
Journal:  Cell Prolif       Date:  2018-07-20       Impact factor: 6.831

5.  Late SV40 factor: a key mediator of Notch signaling in human hepatocarcinogenesis.

Authors:  Ren-Hua Fan; Jing Li; Nan Wu; Ping-Sheng Chen
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

6.  Cooperation of deregulated Notch signaling and Ras pathway in human hepatocarcinogenesis.

Authors:  Renhua Fan; Pingsheng Chen; Di Zhao; Jing Long Tong; Jing Li; Feng Liu
Journal:  J Mol Histol       Date:  2011-09-03       Impact factor: 2.611

7.  The transcription factor LSF: a novel oncogene for hepatocellular carcinoma.

Authors:  Prasanna K Santhekadur; Devaraja Rajasekaran; Ayesha Siddiq; Rachel Gredler; Dong Chen; Scott E Schaus; Ulla Hansen; Paul B Fisher; Devanand Sarkar
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

8.  Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma.

Authors:  Trevor J Grant; Joshua A Bishop; Lisa M Christadore; Girish Barot; Hang Gyeong Chin; Sarah Woodson; John Kavouris; Ayesha Siddiq; Rachel Gredler; Xue-Ning Shen; Jennifer Sherman; Tracy Meehan; Kevin Fitzgerald; Sriharsa Pradhan; Laura A Briggs; William H Andrews; Devanand Sarkar; Scott E Schaus; Ulla Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-06       Impact factor: 11.205

9.  Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma.

Authors:  Byoung Kwon Yoo; Luni Emdad; Rachel Gredler; Christine Fuller; Catherine I Dumur; Kimberly H Jones; Colleen Jackson-Cook; Zao-Zhong Su; Dong Chen; Utsav H Saxena; Ulla Hansen; Paul B Fisher; Devanand Sarkar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

10.  Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.

Authors:  Jithma P Abeykoon; Xiaosheng Wu; Kevin E Nowakowski; Surendra Dasari; Jonas Paludo; S John Weroha; Chunling Hu; Xiaonan Hou; Jann N Sarkaria; Ann C Mladek; Jessica L Phillips; Andrew L Feldman; Aishwarya Ravindran; Rebecca L King; Justin Boysen; Mary J Stenson; Ryan M Carr; Michelle K Manske; Julian R Molina; Prashant Kapoor; Sameer A Parikh; Shaji Kumar; Steven I Robinson; Jia Yu; Judy C Boughey; Liewei Wang; Matthew P Goetz; Fergus J Couch; Mrinal M Patnaik; Thomas E Witzig
Journal:  Blood       Date:  2021-01-28       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.